In vitro and in vivo estrogenicity of UV screens.

Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. · 2001

Read In vitro and in vivo estrogenicity of UV screens. by Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. (2001) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1240241.txt.

Introduction

Schlumpf and co-authors tested sunscreen chemicals for hormone effects in 2001. UV screens guard skin against sun damage and cancer. They also enter cosmetics to keep products stable. Traces had been found building up in wildlife and people.

Six common screens were tested in cells and young rats. Five made breast cancer cells grow faster in dishes. That growth could be blocked by an estrogen blocker drug. In rats, one screen raised womb weight with dose. Schlumpf calls for deeper safety checks on these widely used chemicals. One screen, B-MDM, showed no such activity in cells.

Catalog record

CREATORSchlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W.
YEAR2001
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1240241

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

In vitro and in vivo estrogenicity of UV screens.

By M Schlumpf, B Cotton, M Conscience, V Haller, B Steinmann, W Lichtensteiger

Published in: Environmental Health Perspectives

DOI: 10.1289/ehp.01109239

ABSTRACT

Abstract

Ultraviolet (UV) screens are increasingly used as a result of growing concern about UV radiation and skin cancer; they are also added to cosmetics and other products for light stability. Recent data on bioaccumulation in wildlife and humans point to a need for in-depth analyses of systemic toxicology, in particular with respect to reproduction and ontogeny. We examined six frequently used UVA and UVB screens for estrogenicity in vitro and in vivo. In MCF-7 breast cancer cells, five out of six chemicals, that is, benzophenone-3 (Bp-3), homosalate (HMS), 4-methyl-benzylidene camphor (4-MBC), octyl-methoxycinnamate (OMC), and octyl-dimethyl-PABA (OD-PABA), increased cell proliferation with median effective concentrations (EC(50)) values between 1.56 and 3.73 microM, whereas butyl-methoxydibenzoylmethane (B-MDM) was inactive. Further evidence for estrogenic activity was the induction of pS2 protein in MCF-7 cells and the blockade of the proliferative effect of 4-MBC by the estrogen antagonist ICI 182,780. In the uterotrophic assay using immature Long-Evans rats that received the chemicals for 4 days in powdered feed, uterine weight was dose-dependently increased by 4-MBC (ED(50 )309mg/kg/day), OMC (ED(50) 935 mg/kg/day), and weakly by Bp-3 (active at 1,525 mg/kg/day). Three compounds were inactive by the oral route in the doses tested. Dermal application of 4-MBC to immature hairless (hr/hr) rats also increased uterine weight at concentrations of 5 and 7.5% in olive oil. Our findings indicate that UV screens should be tested for endocrine activity, in view of possible long-term effects in humans and wildlife.

FULL TEXT

The Full Text of this article is available as a PDF (86.9 KB).

SELECTED REFERENCES

These references are in PubMed. This may not be the complete list of references from this article.

Read the complete text